Pharmascience Inc:企業のM&A・事業提携・投資動向

◆英語タイトル:Pharmascience Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
◆商品コード:DATA904C1962
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:66
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD700 ⇒換算¥103,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD1,050 ⇒換算¥155,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Pharmascience Inc – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
Summary

Marketline’s Pharmascience Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Pharmascience Inc since January2007.

Synopsis

Marketline’s Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Key Highlights

This report includes Pharmascience Inc’s contact information and business summary, tables, graphs, a list of partners and targets, a breakdown of financial and legal advisors, deal types, top deals by deal value, detailed deal reports, and descriptions and contact details of the partner, target, investor, and vendor firms, where disclosed.

The profile also includes detailed deal reports for all M&A, private equity, public offering, venture financing, partnership and divestment transactions undertaken by Pharmascience Inc. These deal reports contain information about target company financials, sources of financing, method of payment, deal values, and advisors for various parties, where disclosed.

Scope

- Provides intelligence on Pharmascience Inc’s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
- Detailed reports of various financial transactions undertaken by Pharmascience Inc and its subsidiaries since 2007.
- Information about key financial and legal advisors for Pharmascience Inc’s financial deals transactions.
- Financial deals tables and charts covering deal value and volumes trend, deal types and geography-based deal activity.

Reasons to buy

- Access comprehensive financial deals data along with charts and graph covering M&A, private equity, and partnerships and alliances.
- Form an independent opinion about Pharmascience Inc’s growth strategies through the organic and inorganic activities undertaken since 2007.
- Track your competitors’ business structure and growth strategies.

【レポートの目次】

Table of Contents
COMPANY OVERVIEW AND KEY FACTS 2
TABLE OF CONTENTS 5
LIST OF TABLES 6
LIST OF FIGURES 6
TARGETS AND PARTNERS 7
MERGERS & ACQUISITIONS 8
Mergers and Acquisitions – Overview 8
Mergers and Acquisitions – Deal reports 9
CORPORATE VENTURING 23
Corporate Venturing – Overview 23
Corporate Venturing – Deal reports 24
PARTNERSHIP 35
Partnership – Overview 35
Partnership – Deal reports 36
Divestments – Deal reports 53
APPENDIX 56
Contact Us 56
About MarketLine Financial Deals Database 56
Deal Definition and Methodology 58
About MarketLine 65

List of Tables
Table 1: Pharmascience Inc M&A volume and value trend (2014-YTD2018)
Table 2: Pharmascience Inc M&A activity by geography (2014-YTD2018)
Table 3: Pharmascience Inc corporate venturing volume and value trend (2014-YTD2018)
Table 4: Pharmascience Inc corporate venturing by geography (2014-YTD2018)
Table 5: Pharmascience Inc partnership volume and value trend (2014-YTD2018)
Table 6: Pharmascience Inc partnership trend by key deal type (2014-YTD2018)

List of Figures
Figure 1: Pharmascience Inc M&A volume and value trend (2014-YTD2018)
Figure 2: Pharmascience Inc M&A activity by geography (2014-YTD2018)
Figure 3: Pharmascience Inc corporate venturing volume and value trend (2014-YTD2018)
Figure 4: Pharmascience Inc corporate venturing by geography (2014-YTD2018)
Figure 5: Pharmascience Inc partnership volume and value trend (2014-YTD2018)
Figure 6: Pharmascience Inc partnership trend by key deal type (2014-YTD2018)

★海外企業調査レポート[Pharmascience Inc:企業のM&A・事業提携・投資動向]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Montana Tech Components AG:企業の戦略・SWOT・財務情報
    Montana Tech Components AG - Strategy, SWOT and Corporate Finance Report Summary Montana Tech Components AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Energias de Portugal S.A:企業の戦略・SWOT・財務分析
    Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report Summary Energias de Portugal S.A - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Medigus Ltd (MDGS):医療機器:M&Aディール及び事業提携情報
    Summary Medigus Ltd (Medigus) is a medical device company that develops minimally invasive endosurgical tools and imaging solutions across medical and industrial applications. The company’s muse system enables endoscopists to treat gastroesophageal reflux disease (GERD) by performing fundoplication …
  • Silverleaf Resorts, Inc.:企業の戦略・SWOT・財務情報
    Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silverleaf Resorts, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Simon Property Group, Inc.:企業の戦略・SWOT・財務情報
    Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Simon Property Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Centers for Disease Control and Prevention:医療機器:M&Aディール及び事業提携情報
    Summary Centers for Disease Control and Prevention (CDC) a subsidiary of US Department of Health and Human Services is a public health institute that offers health, safety and security threat management solutions. The institute provides health information to fight diseases and support communities fr …
  • Eurofins Scientific SE:戦略・SWOT・企業財務分析
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • John Keells Holdings PLC (JKH.N0000):企業の財務・戦略的SWOT分析
    Summary John Keells Holdings PLC (John Keells) is a business and consumer services company that provides hotel management services. The company offers services such as airline and aviation services, cinnamon hotels and resorts services, holiday and tour consulting services, port and marine fuel serv …
  • Henry Schein Inc (HSIC):医療機器:M&Aディール及び事業提携情報
    Summary Henry Schein Inc (Henry Schein) is a distributor of medical, dental and veterinary products including vaccines, medicines and equipment. Its product portfolio consists of dental, medical and animal health products, software and technology and other value-added services, besides financial ser …
  • Sahara Petrochemicals Co:企業の戦略的SWOT分析
    Sahara Petrochemicals Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Hill International, Inc. (HIL):企業の財務・戦略的SWOT分析
    Hill International, Inc. (HIL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Cyclacel Pharmaceuticals Inc (CYCC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cyclacel Pharmaceuticals Inc (Cyclacel) is a biopharmaceutical company that develops oral therapies. The company develops small molecule drugs that target various phases of cell cycle control for the treatment of cancer and other serious diseases. Its products include sapacitabine, selicicli …
  • VWR Corp (VWR)-医療機器分野:企業M&A・提携分析
    Summary VWR Corp (VWR) is a medical equipment company that distributes laboratory products, and provides services and solutions. The company offers product such chemicals, reagents, consumables, durable products, scientific equipment and instruments. It offers products in the areas of research and d …
  • LGC Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary LGC Ltd (LGC), formerly LGC (Teddington) Ltd is a life sciences measurement and testing company that offers reference materials, genomics solutions and analytical testing products and services. The company’s products comprise DNA extraction instrumentation, DNA extraction kits, Douglas scien …
  • BL&H Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary BL&H Co Ltd (BL&H), a subsidiary of STADA Pharmaceuticals (Asia) Ltd is a drug company that manufactures and markets diagnostic test kits and drugs. The company offers products including aridol bronchial challenge test kit, cetraxal plus ear drop, al-sense amniotic leak test kit, DC bead-dru …
  • Amcor Ltd:企業のM&A・事業提携・投資動向
    Amcor Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amcor Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Foundation Radiology Group PC:医療機器:M&Aディール及び事業提携情報
    Summary Foundation Radiology Group PC (FRG) is a provider of radiology solutions. The company offers radiological services in areas of pediatric, neurology, mammography, musculoskeletal, PET and CT, cardiac CT and interventional radiology. It offers imaging solutions for the radiologists and systems …
  • Oki Electric Industry Co., Ltd.:企業の戦略・SWOT・財務分析
    Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Oki Electric Industry Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • John Keells Hotels Plc:企業の戦略・SWOT・財務分析
    John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report Summary John Keells Hotels Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • PharmaCyte Biotech Inc (PMCB):製薬・医療:M&Aディール及び事業提携情報
    Summary PharmaCyte Biotech Inc (PharmaCyte), formerly Nuvilex Inc, is a clinical stage biotechnology company that develops and commercializes treatments for cancer and diabetes. The company offers technology is used for the treatment of advanced and inoperable pancreatic cancer and diabetes. It deve …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆